European Commission Investment Plan for Europe

Caverion Corporation's Financial Statement Release for 1 January - 31 December 2021

Retrieved on: 
木曜日, 2月 10, 2022
Annual Review, Multi-project wafer service, Sick leave, Maintenance, News, Growth, NZEB, EEST, Awareness, European Commission Investment Plan for Europe, Automation, Solution, Investment, Vaccination, ECB, MEPS, Technology, EET, EPBD, Built environment, Housing, Coordinated Annual Review on Defence, Capital market, Refrigeration, European Commission, Minimum energy performance standard, Goal, ISO 50001, Campus carbon neutrality, Environment, Carbon, Carbon footprint, Legislation, Building, Smart Technologies, Mission statement, Project, Renewable energy, Animal, Service, EU, Caverion

HELSINKI, Feb. 10, 2022 /PRNewswire/ --

Key Points: 
  • Caverion also reaffirms its sustainability target of having a positive carbon handprint five times greater than its carbon footprint by 2025.
  • Caverion expects market demand to be overall positive in Services and to improve also in Projects during 2022.
  • Caverion will hold a news conference on its Financial Statement Release on Thursday, 10 February 2022, at 10.00 a.m. Finnish time (EET).
  • The Annual Review, including the financial statements for 2021, will be published on Caverion's website in English and Finnish by 4 March 2022 at the latest.

ValueBlue Raises $11 Million to Fuel Agile Business Transformation Worldwide

Retrieved on: 
火曜日, 1月 18, 2022
Octopus Group, APAC, European Commission Investment Plan for Europe, ABN AMRO, Union, Enterprise Architect (software), Enterprise, CEO, Digital, EA, A.S. Watson Group, Venture capital, Solution, Committee on European Affairs and Oversight of the European Funds, Health, CIOS, Industry, EFSI, Software as a service, Architecture, Wyndham Hotels & Resorts, Twitter, Microsoft, Coronavirus, Google, ABN, Financial services, Management, Cryptocurrency, Amazon, EMEA, Randstad, Deloitte

ValueBlue's collaborative EA platform provides unprecedented business insights that are crucial for planning and structuring as enterprises go digital.

Key Points: 
  • ValueBlue's collaborative EA platform provides unprecedented business insights that are crucial for planning and structuring as enterprises go digital.
  • ValueBlue has been addressing the growing need for agile business transformation since 2011 and the latest capital injection comes at a critical time.
  • ValueBlue is the leading company behind the Enterprise SaaS tool that helps CIOs and Enterprise Architects plan, collaborate, and manage business transformation.
  • The collaboration platform speeds up Agile Business Transformation for CIOs and Enterprise Architects across the globe.

Mr. Michael Coletta Joins Fineqia as Chief Strategy Officer

Retrieved on: 
月曜日, 12月 6, 2021
Bitcoin, Crypto, CEO, CSO, Technology, London Stock Exchange Group, DG, Company, CME Group, European Commission Investment Plan for Europe, Fed, Blockchain, FNQ, CSE, Investment, Science and technology in Asia, LSEG, CME, Marketing, Culture, The Company, OTC, European Commission, Hyco International Inc, International Television Expert Group, Mica, Multimedia, GBBC, NASDAQ, Growth, Cryptocurrency, Financial services, Online shopping

LONDON, Dec. 6, 2021 /PRNewswire/ -Fineqia International Inc. (the "Company" or "Fineqia") (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) is proud to announce that Michael Coletta, a financial markets and fintech 15 year veteran joins the senior management team as a Chief Strategy Officer (CSO).

Key Points: 
  • LONDON, Dec. 6, 2021 /PRNewswire/ -Fineqia International Inc. (the "Company" or "Fineqia") (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) is proud to announce that Michael Coletta, a financial markets and fintech 15 year veteran joins the senior management team as a Chief Strategy Officer (CSO).
  • Mr. Coletta joins Fineqia after a successful tenure at the London Stock Exchange Group (LSEG) and the CME Group (NASDAQ: CME), the world's largest derivates exchange based in the U.S.
  • In his previous role at LSEG, Mr. Coletta developed a technology-driven business transformation strategy for adopting blockchain and digital assets across LSEG's capital markets, post trade, benchmarks, and technology infrastructure businesses.
  • Mr. Coletta has served as an Operating Committee member for the Global Blockchain Business Council (GBBC - PTDL Group) along with Global Digital Finance.

Median Technologies Announces New Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization

Retrieved on: 
火曜日, 11月 23, 2021
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, NSCLC, Liver cancer, AI, International Association, Diagnosis, Prognosis, Lung cancer, LCS, EIB, Cade, CEO, RSNA, Cancer, Precision medicine, Liver disease, DS, National Lung Screening Trial, NLST, European Commission Investment Plan for Europe, Death, Research, HCC, BPI, Exhibition, Euronext Growth, Committee on European Affairs and Oversight of the European Funds, Solution, Survival, Radiology, Artificial intelligence, Literature, Ginkgo CADx, FDA, SME, Patient, Adoption, Biomarker, Technology, European Investment Bank, Non-small-cell lung carcinoma, Malignancy, Data science, NASH, AUC, Disease, Medical imaging

Median Technologies (Paris:ALMDT) (ALMDT:PA) announces new outstanding performance of its lung cancer screening (LCS) CADx to characterize malignant vs. benign lung nodules.

Key Points: 
  • Median Technologies (Paris:ALMDT) (ALMDT:PA) announces new outstanding performance of its lung cancer screening (LCS) CADx to characterize malignant vs. benign lung nodules.
  • New results specifically focus on the characterization of stage 1 lung cancer nodules, using Medians proprietary iBiopsy deep learning algorithm on low-dose chest computed tomography (LDCT).
  • Lung cancer is the number one cancer killer globally, causing an estimate of 1.8m deaths, accounting for 18% of all cancer deaths in 20202.
  • A noteworthy International Early Lung Cancer Action Program (I-ELCAP) cohort study of stage 1 cancer patients4 revealed an excellent 15-year LCS survival of 92% which again serves to show how critical early stage diagnosis via lung cancer screening remains.

Caverion Corporation's Interim Report for 1 January - 30 September 2021

Retrieved on: 
木曜日, 11月 4, 2021
EPBD, Campus carbon neutrality, Technology, EBITA, Goal, Mission statement, Vaccination, Smart Technologies, NZEB, EEST, Coordinated Annual Review on Defence, ISO 50001, EUR, Capital market, Refrigeration, Household Service Demonstration Project, European Commission, European Commission Investment Plan for Europe, Maintenance, EET, Investment, Growth, Investor relations, Awareness, Environment, Annual Review, LTM, News, Solution, Building, Multi-project wafer service, Legislation, Automation, Video game, Animal, Marketing, Renewable energy

HELSINKI, Nov. 4, 2021 /PRNewswire/ -- 1 July – 30 September 2021

Key Points: 
  • "I am satisfied with our profitability improvement continuing according to plan in the third quarter of 2021.
  • The business mix change seen in recent years follows our plans; the Services business accounted for 65.1 (62.6) percent of Group revenue in January-September 2021.
  • Caverion expects market demand to be overall positive in Services and to improve also in Projects during the end of 2021.
  • Caverion expects the national and EU programmes to increase demand also in Caverion's areas of operation as of the end of 2021.

Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers

Retrieved on: 
金曜日, 10月 22, 2021
Biotechnology, Health, Other Health, Radiology, Pharmaceutical, Stem Cells, Oncology, Other Science, Research, Medical Devices, Infectious Diseases, Genetics, Science, Clinical Trials, Cloud, Curie Institute (Paris), Norwest Venture Partners, Ipsen, Organization, Partnership, SPAC, Boehringer Ingelheim, EFSI, Degenerative disease, European Commission Investment Plan for Europe, Therapy, Doctor of Philosophy, Takeda Pharmaceutical Company, Research, Quality of life, European Union, View, LP record, List of life sciences, INSERM, LSP, Lead, Education, Physician, Committee on European Affairs and Oversight of the European Funds, Industry, Investment, TVI, Immunity, CEO, Growth, Union, Gastroenterology, Institute, Cancer, Neurodegeneration, Patient, Neuroscience, Felice, BMS, Pharmaceutical industry, Vaccine, Financial services, Fine chemical, Egle Therapeutics, LSP, Bpifrance – InnoBio 2, Takeda Ventures Inc., Fund+, Bioqube Ventures, Institut Curie, EGLE THERAPEUTICS, LSP, BPIFRANCE – INNOBIO 2, TAKEDA VENTURES INC., FUND+, BIOQUBE VENTURES, INSTITUT CURIE

The Series A was co-led by LSP and Bpifrance through their InnoBio 2 fund.

Key Points: 
  • The Series A was co-led by LSP and Bpifrance through their InnoBio 2 fund.
  • The new capital will be used primarily to advance 2 leads assets into the clinic and further strengthen its internal drug pipeline.
  • The investor syndicate will join the Egle Therapeutics Board which will consist of Felice Verduyn-van Weegen (LSP), Vincent Brichard (LSP), Jean-Francois Morin (Bpifrance InnoBio 2) and Sacha Mann (Takeda Ventures).
  • Philippe Monteyne (Fund+), Jacques Mizrahi (Bioqube Ventures) and Elisa El Nouchi (Bpifrance InnoBio 2) will join as observers.

TECO 2030 Signs Supply Frame Agreement with Chemgas Shipping

Retrieved on: 
木曜日, 10月 14, 2021
Hydrogen, TECO, Technology, ASA, OTCQB, Water, River, Enger, Microbial contamination of diesel fuel, Classification, DNV, AIP, AVL, Transport, Revolution, NORWAY, Electricity, European Commission Investment Plan for Europe, NEWS, Wind, Carbon, CEO, European Commission, Letter, Verbund, Renewable energy, Canal, Oil, Coal

LYSAKER, NORWAY / ACCESSWIRE / October 14, 2021 / Norwegian maritime cleantech company TECO 2030 ASA (OTCQB:TECFF) has signed a supply frame agreement with the Dutch shipowner Chemgas Shipping BV.

Key Points: 
  • LYSAKER, NORWAY / ACCESSWIRE / October 14, 2021 / Norwegian maritime cleantech company TECO 2030 ASA (OTCQB:TECFF) has signed a supply frame agreement with the Dutch shipowner Chemgas Shipping BV.
  • Chemgas Shipping plans to install fuel cell modules from TECO 2030 on up to 120 transport barges and between 40-60 tugboats.
  • "We are thrilled that Chemgas Shipping has chosen to cooperate with TECO 2030 on this ambitious and important project, and that we have now been able to progress from a letter of intent to a supply frame agreement," says Tore Enger, CEO of TECO 2030 ASA.
  • "The economic potential of this framework agreement is large for TECO 2030 and may lead to revenues of up to 150 million Euros over the next three to eight years," Enger adds.

The Infinity Group: Alternative Funding Options Help EU Companies Capitalize on Economic Recovery Plan to Grow Back Greener, Digital and Resilient

Retrieved on: 
木曜日, 9月 30, 2021
Union, European Commission, Infinity Group, European Union, European Commission Investment Plan for Europe, Growth, Infinity, Security (finance)

The challenge is accessing the capital to expand businesses quickly enough to leverage this unique window of opportunity.

Key Points: 
  • The challenge is accessing the capital to expand businesses quickly enough to leverage this unique window of opportunity.
  • This is particularly challenging at a time when damaged supply chains continue to add costs to operations and traditional financing remain expensive and scarce, this according to The Infinity Group.
  • However, The Infinity group is seeing hedge funds, pension funds, sovereign wealth groups, angel investors and others from around the world seeking to capitalize on these unique conditions.
  • The Infinity Group is among an emerging category of financial service groups offering an alternative funding model that provides growth potential for both companies and investors.

The Infinity Group: Alternative Funding Options Help EU Companies Capitalize on Economic Recovery Plan to Grow Back Greener, Digital and Resilient

Retrieved on: 
木曜日, 9月 30, 2021
Union, European Commission, Infinity Group, European Union, European Commission Investment Plan for Europe, Growth, Infinity, Security (finance)

The challenge is accessing the capital to expand businesses quickly enough to leverage this unique window of opportunity.

Key Points: 
  • The challenge is accessing the capital to expand businesses quickly enough to leverage this unique window of opportunity.
  • This is particularly challenging at a time when damaged supply chains continue to add costs to operations and traditional financing remain expensive and scarce, this according to The Infinity Group.
  • However, The Infinity group is seeing hedge funds, pension funds, sovereign wealth groups, angel investors and others from around the world seeking to capitalize on these unique conditions.
  • The Infinity Group is among an emerging category of financial service groups offering an alternative funding model that provides growth potential for both companies and investors.

Nanoform Shortlisted For The European Small and Mid-Cap Awards 2021

Retrieved on: 
木曜日, 9月 23, 2021
China-EU Institute for Clean and Renewable Energy, GMP, European Single Market, Goal, Entrepreneurship, Public, EuropeanIssuers, European Small and Mid-Cap Awards, Patient, SME, Royal commission, Growth, DG, Strategic autonomy, Affiliation, IPO, European Commission, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, Innovation, Award, European Commission Investment Plan for Europe, Federation, Security (finance), Renewable energy

HELSINKI, Sept. 23, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has made the shortlist in the `Star of Innovation' category of the 9th annual European Small and Mid-Cap Awards.

Key Points: 
  • HELSINKI, Sept. 23, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has made the shortlist in the `Star of Innovation' category of the 9th annual European Small and Mid-Cap Awards.
  • Nanoform, listed on Nasdaq, was shortlisted from some 27 nominations from 17 countries, listed on different European stock exchanges.
  • They will be revealed at a special Awards ceremony on 16th November during the European Commission's SME Assembly in Portoro, Slovenia.
  • The European Small and Mid-Cap Awards advocate the benefits of equity financing and encourage smaller companies to consider this financing option.